In-depth characterization of neuroradiological findings in a large sample of individuals with autism spectrum disorder and controls.


Journal

NeuroImage. Clinical
ISSN: 2213-1582
Titre abrégé: Neuroimage Clin
Pays: Netherlands
ID NLM: 101597070

Informations de publication

Date de publication:
2022
Historique:
received: 20 12 2021
revised: 14 06 2022
accepted: 12 07 2022
pubmed: 23 7 2022
medline: 25 8 2022
entrez: 22 7 2022
Statut: ppublish

Résumé

Autism spectrum disorder (ASD) is a group of neurodevelopmental conditions associated with quantitative differences in cortical and subcortical brain morphometry. Qualitative assessment of brain morphology provides complementary information on the possible underlying neurobiology. Studies of neuroradiological findings in ASD have rendered mixed results, and await robust replication in a sizable and independent sample. We systematically and comprehensively assessed neuroradiological findings in a large cohort of participants with ASD and age-matched controls (total N = 620, 348 ASD and 272 controls), including 70 participants with intellectual disability (47 ASD, 23 controls). We developed a comprehensive scoring system, augmented by standardized biometric measures. There was a higher incidence of neuroradiological findings in individuals with ASD (89.4 %) compared to controls (83.8 %, p = .042). Certain findings were also more common in ASD, in particular opercular abnormalities (OR 1.9, 95 % CI 1.3-3.6) and mega cisterna magna (OR 2.4, 95 % CI 1.4-4.0) reached significance when using FDR, whereas increases in macrocephaly (OR 2.0, 95 % CI 1.2-3.2), cranial deformities (OR 2.4, 95 % CI: 1.0-5.8), calvarian / dural thickening (OR 1.5, 95 % CI 1.0-2.3), ventriculomegaly (OR 3.4, 95 % CI 1.3-9.2), and hypoplasia of the corpus callosum (OR 2.7, 95 % CI 1.1-6.3) did not survive this correction. Furthermore, neuroradiological findings were more likely to occur in isolation in controls, whereas they clustered more frequently in ASD. The incidence of neuroradiological findings was higher in individuals with mild intellectual disability (95.7 %), irrespective of ASD diagnosis. There was a subtly higher prevalence of neuroradiological findings in ASD, which did not appear to be specific to the condition. Individual findings or clusters of findings may point towards the neurodevelopmental mechanisms involved in individual cases. As such, clinical MRI assessments may be useful to guide further etiopathological (genetic) investigations, and are potentially valuable to fundamental ASD research.

Sections du résumé

BACKGROUND
Autism spectrum disorder (ASD) is a group of neurodevelopmental conditions associated with quantitative differences in cortical and subcortical brain morphometry. Qualitative assessment of brain morphology provides complementary information on the possible underlying neurobiology. Studies of neuroradiological findings in ASD have rendered mixed results, and await robust replication in a sizable and independent sample.
METHODS
We systematically and comprehensively assessed neuroradiological findings in a large cohort of participants with ASD and age-matched controls (total N = 620, 348 ASD and 272 controls), including 70 participants with intellectual disability (47 ASD, 23 controls). We developed a comprehensive scoring system, augmented by standardized biometric measures.
RESULTS
There was a higher incidence of neuroradiological findings in individuals with ASD (89.4 %) compared to controls (83.8 %, p = .042). Certain findings were also more common in ASD, in particular opercular abnormalities (OR 1.9, 95 % CI 1.3-3.6) and mega cisterna magna (OR 2.4, 95 % CI 1.4-4.0) reached significance when using FDR, whereas increases in macrocephaly (OR 2.0, 95 % CI 1.2-3.2), cranial deformities (OR 2.4, 95 % CI: 1.0-5.8), calvarian / dural thickening (OR 1.5, 95 % CI 1.0-2.3), ventriculomegaly (OR 3.4, 95 % CI 1.3-9.2), and hypoplasia of the corpus callosum (OR 2.7, 95 % CI 1.1-6.3) did not survive this correction. Furthermore, neuroradiological findings were more likely to occur in isolation in controls, whereas they clustered more frequently in ASD. The incidence of neuroradiological findings was higher in individuals with mild intellectual disability (95.7 %), irrespective of ASD diagnosis.
CONCLUSION
There was a subtly higher prevalence of neuroradiological findings in ASD, which did not appear to be specific to the condition. Individual findings or clusters of findings may point towards the neurodevelopmental mechanisms involved in individual cases. As such, clinical MRI assessments may be useful to guide further etiopathological (genetic) investigations, and are potentially valuable to fundamental ASD research.

Identifiants

pubmed: 35868222
pii: S2213-1582(22)00183-8
doi: 10.1016/j.nicl.2022.103118
pmc: PMC9421485
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

103118

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.

Références

Brain. 2014 Jun;137(Pt 6):1579-613
pubmed: 24477430
J Child Neurol. 2014 Dec;29(12):1626-31
pubmed: 24346312
Am J Psychiatry. 2022 Mar;179(3):242-254
pubmed: 34503340
J Anat. 1969 Nov;105(Pt 3):467-75
pubmed: 4187088
Pediatr Res. 2011 May;69(5 Pt 2):63R-8R
pubmed: 21289538
AJR Am J Roentgenol. 2018 Apr;210(4):848-859
pubmed: 29470161
Neurosci Bull. 2021 Jul;37(7):1051-1071
pubmed: 33779890
AJNR Am J Neuroradiol. 2002 Nov-Dec;23(10):1674-7
pubmed: 12427622
J Autism Dev Disord. 1999 Apr;29(2):113-9
pubmed: 10382131
Lancet Neurol. 2015 Nov;14(11):1121-34
pubmed: 25891007
Neuroimage. 2012 Aug 15;62(2):774-81
pubmed: 22248573
N Engl J Med. 2017 Oct 19;377(16):1593-1595
pubmed: 29045203
Radiology. 2006 Jun;239(3):650-64
pubmed: 16714456
Radiographics. 2015 Jan-Feb;35(1):200-20
pubmed: 25590398
AJNR Am J Neuroradiol. 1995 Sep;16(8):1677-87
pubmed: 7502974
Hum Brain Mapp. 2010 Apr;31(4):556-66
pubmed: 19790171
Dental Press J Orthod. 2013 May-Jun;18(3):159-63
pubmed: 24094027
Sci Rep. 2020 Dec 29;10(1):22417
pubmed: 33376247
Neurol Res. 2011 Dec;33(10):1044-9
pubmed: 22196757
J Child Neurol. 2000 Feb;15(2):102-8
pubmed: 10695895
AJR Am J Roentgenol. 1989 Dec;153(6):1289-300
pubmed: 2816648
Neuroimage Clin. 2015 Feb 20;7:631-9
pubmed: 25844317
AJNR Am J Neuroradiol. 2019 Feb;40(2):340-346
pubmed: 30679220
Neuroradiology. 2013 Nov;55(11):1333-9
pubmed: 24036927
J Autism Dev Disord. 2000 Jun;30(3):205-23
pubmed: 11055457
Epidemiol Psychiatr Sci. 2013 Sep;22(3):217-21
pubmed: 23531487
J Child Neurol. 2016 Dec;31(14):1611-1616
pubmed: 27629267
JAMA. 1999 Jul 7;282(1):36-9
pubmed: 10404909
Development. 2020 Sep 28;147(18):
pubmed: 32988974
J Am Acad Child Adolesc Psychiatry. 1997 Feb;36(2):282-90
pubmed: 9031582
Dev Cogn Neurosci. 2016 Jun;19:137-43
pubmed: 26999477
Surg Neurol Int. 2012;3(Suppl 3):S232-7
pubmed: 22905329
Child Adolesc Ment Health. 2013 Feb;18(1):52-63
pubmed: 23539140
Mol Autism. 2017 Jun 23;8:24
pubmed: 28649312
Brain Res Bull. 2003 Oct 15;61(6):557-69
pubmed: 14519452
Brain. 2012 May;135(Pt 5):1348-69
pubmed: 22427329
J Autism Dev Disord. 2012 Aug;42(8):1662-70
pubmed: 22105143
PLoS One. 2009;4(2):e4415
pubmed: 19204795
Mol Psychiatry. 2002;7 Suppl 2:S21-3
pubmed: 12142938
Neurology. 2000 Aug 22;55(4):468-79
pubmed: 10953176
Autism Res. 2017 Jan;10(1):113-120
pubmed: 27874265
AJNR Am J Neuroradiol. 1989 Sep-Oct;10(5):929-36
pubmed: 2505536
Neurology. 2002 Jul 23;59(2):175-83
pubmed: 12136053
J Neurosci. 2007 Oct 24;27(43):11725-35
pubmed: 17959814
AJNR Am J Neuroradiol. 1996 Aug;17(7):1303-11
pubmed: 8871716
J Comput Assist Tomogr. 2004 Mar-Apr;28(2):263-8
pubmed: 15091132
Pediatr Neurosurg. 2015;50(1):12-7
pubmed: 25613691
AJNR Am J Neuroradiol. 2011 Sep;32(8):1436-43
pubmed: 21799035
Ann Neurol. 2016 Dec;80(6):797-810
pubmed: 27862206
Biol Psychiatry. 2009 Nov 15;66(10):935-41
pubmed: 19748080
J Anat. 2017 Jan;230(1):4-15
pubmed: 27620360
AJR Am J Roentgenol. 2008 Jun;190(6):1637-43
pubmed: 18492918
Brain Res. 2011 Mar 22;1380:138-45
pubmed: 20920490
JAMA Psychiatry. 2013 Jan;70(1):59-70
pubmed: 23404046
Am J Psychiatry. 1990 Jun;147(6):734-9
pubmed: 2343916
Am J Psychiatry. 2022 May;179(5):336-349
pubmed: 35331004
Cereb Cortex. 2006 Sep;16(9):1276-82
pubmed: 16306324
Schizophr Bull. 2013 Jul;39(4):815-9
pubmed: 22416264
Pediatr Neurol. 2005 Feb;32(2):102-8
pubmed: 15664769
Neurology. 2001 Jul 24;57(2):245-54
pubmed: 11468308
Am J Psychiatry. 2018 Apr 1;175(4):359-369
pubmed: 29145754
Genet Med. 2013 May;15(5):399-407
pubmed: 23519317
Brain Dev. 2006 Sep;28(8):495-9
pubmed: 16616445
Am J Med Genet A. 2009 Jan;149A(1):6-28
pubmed: 19125436
J Child Neurol. 2015 Oct;30(12):1658-63
pubmed: 25895913

Auteurs

Sara Ambrosino (S)

University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: S.AmbrosinodiBruttopilo-3@umcutrecht.nl.

Hasnaa Elbendary (H)

Clinical Genetics Department, Human Genetics and Genome Research Division of the National Research Center, Cairo, Egypt.

Maarten Lequin (M)

Department of Radiology, University Medical Center Utrecht, Utrecht, the Netherlands.

Dominique Rijkelijkhuizen (D)

University Medical Center Utrecht, Utrecht, the Netherlands; Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands.

Tobias Banaschewski (T)

Department of Child and Adolescent Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

Simon Baron-Cohen (S)

Autism Research Centre, Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom.

Nico Bast (N)

Department of Child and Adolescent Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

Sarah Baumeister (S)

Department of Child and Adolescent Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

Jan Buitelaar (J)

Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands.

Tony Charman (T)

Department of Psychology, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.

Daisy Crawley (D)

Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, United Kingdom.

Flavio Dell'Acqua (F)

Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, United Kingdom.

Hannah Hayward (H)

Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, United Kingdom.

Rosemary Holt (R)

Autism Research Centre, Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom.

Carolin Moessnang (C)

Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany.

Antonio M Persico (AM)

Child and Adolescent Neuropsychiatry Program at Modena University Hospital, & Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy; Child Neuropsychiatry / Neurodevelopmental Disorders Unit, University "Campus Bio-Medico", Rome, Italy.

Roberto Sacco (R)

Child Neuropsychiatry / Neurodevelopmental Disorders Unit, University "Campus Bio-Medico", Rome, Italy.

Antonia San José Cáceres (A)

Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, United Kingdom; Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Madrid and CIBERSAM (Centro Investigación Biomédica en Red Salud Mental), Spain.

Julian Tillmann (J)

Roche Pharma Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.

Eva Loth (E)

Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, United Kingdom.

Christine Ecker (C)

Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, United Kingdom; Department of Child and Adolescent Psychiatry, University Hospital, Goethe University, Frankfurt am Main, Germany.

Bob Oranje (B)

Center for Neuropsychiatric Schizophrenia Research (CNSR) and Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS), Mental Health Centre Glostrup, University of Copenhagen, Glostrup, Denmark.

Declan Murphy (D)

Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, United Kingdom.

Sarah Durston (S)

University Medical Center Utrecht, Utrecht, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH